FDA Approves New Drug to Treat Bladder Cancer

THURSDAY, May 19, 2016 — A new drug to treat bladder cancer was approved by the U.S. Food and Drug Administration on Wednesday.
Tecentriq (atezolizumab) treats the most common type of bladder cancer, called urothelial carcinoma. It’s the first in…
Source: Topamax